Equity
AOCI
Boston Scientific AOCI increased by 34.8% to -$398M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1321.4%, from -$28M to -$398M. Over 5 years (FY 2020 to FY 2025), AOCI shows a downward trend with a 24.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ4 2013
Last reportedQ1 2026May 1, 2026
How to read this metric
High volatility in this metric can indicate exposure to currency fluctuations or interest rate changes affecting hedging instruments.
Detailed definition
Accumulated Other Comprehensive Income includes unrealized gains and losses that are excluded from net income. This incl...
Peer comparison
Common for multinational firms with significant international operations and complex hedging strategies.
Metric ID:
aociHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $237M | $238M | $263M | $222M | $433M | $532M | $269M | $178M | $208M | $231M | $49M | $132M | $164M | -$128M | $275M | -$28M | -$722M | -$689M | -$610M | -$398M |
| QoQ Change | — | +0.4% | +10.5% | -15.6% | +95.0% | +22.9% | -49.4% | -33.8% | +16.9% | +11.1% | -78.8% | +169.4% | +24.2% | -178.0% | +314.8% | -110.2% | <-999% | +4.6% | +11.5% | +34.8% |
| YoY Change | — | — | — | — | +82.7% | +123.5% | +2.3% | -19.8% | -52.0% | -56.6% | -81.8% | -25.8% | -21.2% | -155.4% | +461.2% | -121.2% | -540.2% | -438.3% | -321.8% | <-999% |
Range-$722M – $532M
CAGR+11.5%
Avg YoY Growth-155.4%
Median YoY Growth-54.3%
Current Streak3 quarters growth
AOCI at Other Companies
Frequently Asked Questions
- What is Boston Scientific's aoci?
- Boston Scientific (BSX) reported aoci of -$398M in Q1 2026.
- How has Boston Scientific's aoci changed year-over-year?
- Boston Scientific's aoci decreased by 1321.4% year-over-year, from -$28M to -$398M.
- What is the long-term trend for Boston Scientific's aoci?
- Over 5 years (2020 to 2025), Boston Scientific's aoci has grown at a 24.1% compound annual growth rate (CAGR), from $207M to -$610M.
- What does aoci mean?
- Cumulative gains or losses not yet realized through actual transactions.